The Journal of Physical Chemistry B,
Journal Year:
2024,
Volume and Issue:
128(19), P. 4696 - 4715
Published: May 2, 2024
In
this
study,
we
combined
AlphaFold-based
atomistic
structural
modeling,
microsecond
molecular
simulations,
mutational
profiling,
and
network
analysis
to
characterize
binding
mechanisms
of
the
SARS-CoV-2
spike
protein
with
host
receptor
ACE2
for
a
series
Omicron
XBB
variants
including
XBB.1.5,
XBB.1.5+L455F,
XBB.1.5+F456L,
XBB.1.5+L455F+F456L.
dynamic
modeling
Spike
lineages
can
accurately
predict
experimental
structures
conformational
ensembles
complexes
ACE2.
Microsecond
dynamics
simulations
identified
important
differences
in
landscapes
equilibrium
variants,
suggesting
that
combining
AlphaFold
predictions
multiple
conformations
provide
complementary
approach
characterization
functional
states
mechanisms.
Using
ensemble-based
profiling
residues
physics-based
rigorous
calculations
affinities,
energy
hotspots
characterized
basis
underlying
epistatic
couplings
between
convergent
hotspots.
Consistent
experiments,
results
revealed
mediating
role
Q493
hotspot
synchronization
L455F
F456L
mutations,
providing
quantitative
insight
into
energetic
determinants
lineages.
We
also
proposed
network-based
perturbation
allosteric
communications
uncovered
relationships
centers
long-range
communication
couplings.
The
study
support
mechanism
which
may
be
determined
by
effects
evolutionary
control
binding.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 13, 2024
Abstract
The
unceasing
circulation
of
SARS-CoV-2
leads
to
the
continuous
emergence
novel
viral
sublineages.
Here,
we
isolate
and
characterize
XBB.1,
XBB.1.5,
XBB.1.9.1,
XBB.1.16.1,
EG.5.1.1,
EG.5.1.3,
XBF,
BA.2.86.1
JN.1
variants,
representing
>80%
circulating
variants
in
January
2024.
XBB
subvariants
carry
few
but
recurrent
mutations
spike,
whereas
harbor
>30
additional
changes.
These
replicate
IGROV-1
no
longer
Vero
E6
are
not
markedly
fusogenic.
They
potently
infect
nasal
epithelial
cells,
with
EG.5.1.3
exhibiting
highest
fitness.
Antivirals
remain
active.
Neutralizing
antibody
(NAb)
responses
from
vaccinees
BA.1/BA.2-infected
individuals
lower
compared
BA.1,
without
major
differences
between
variants.
An
breakthrough
infection
enhances
NAb
against
both
BA.2.86
displays
affinity
ACE2
higher
immune
evasion
properties
BA.2.86.1.
Thus,
while
distinct,
evolutionary
trajectory
these
combines
increased
fitness
evasion.
Cell Host & Microbe,
Journal Year:
2024,
Volume and Issue:
32(3), P. 315 - 321.e3
Published: Feb. 19, 2024
COVID-19
vaccines
have
recently
been
updated
to
specifically
encode
or
contain
the
spike
protein
of
SARS-CoV-2
XBB.1.5
subvariant,
but
their
immunogenicity
in
humans
has
yet
be
fully
evaluated
and
reported,
particularly
against
emergent
viruses
that
are
rapidly
expanding.
We
now
report
administration
an
monovalent
mRNA
vaccine
booster
(XBB.1.5
MV)
previously
uninfected
individuals
boosted
serum
virus-neutralizing
antibodies
significantly
not
only
(27.0-fold
increase)
EG.5.1
(27.6-fold
also
key
emerging
such
as
HV.1,
HK.3,
JD.1.1,
JN.1
(13.3-
27.4-fold
increase).
Individuals
infected
by
Omicron
subvariant
had
highest
overall
neutralizing
titers
(ID
Cell,
Journal Year:
2024,
Volume and Issue:
187(3), P. 585 - 595.e6
Published: Jan. 8, 2024
Evolution
of
SARS-CoV-2
requires
the
reassessment
current
vaccine
measures.
Here,
we
characterized
BA.2.86
and
XBB-derived
variant
FLip
by
investigating
their
neutralization
alongside
D614G,
BA.1,
BA.2,
BA.4/5,
XBB.1.5,
EG.5.1
sera
from
3-dose-vaccinated
bivalent-vaccinated
healthcare
workers,
XBB.1.5-wave-infected
first
responders,
monoclonal
antibody
(mAb)
S309.
We
assessed
biology
spikes
measuring
viral
infectivity
membrane
fusogenicity.
is
less
immune
evasive
compared
to
other
XBB
variants,
consistent
with
antigenic
distances.
Importantly,
distinct
mAb
S309
was
unable
neutralize
BA.2.86,
likely
due
a
D339H
mutation
based
on
modeling.
had
relatively
high
fusogenicity
in
CaLu-3
cells
but
low
fusion
293T-ACE2
some
suggesting
potentially
different
conformational
stability
spike.
Overall,
our
study
underscores
importance
surveillance
need
for
updated
COVID-19
vaccines.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 12, 2023
Evolution
of
SARS-CoV-2
requires
the
reassessment
current
vaccine
measures.
Here,
we
characterized
BA.2.86
and
XBB-lineage
variant
FLip
by
investigating
their
neutralization
alongside
D614G,
BA.1,
BA.2,
BA.4/5,
XBB.1.5,
EG.5.1
sera
from
3-dose
vaccinated
bivalent
healthcare
workers,
XBB.1.5-wave
infected
first
responders,
monoclonal
antibody
(mAb)
S309.
We
assessed
biology
Spikes
measuring
viral
infectivity
membrane
fusogenicity.
is
less
immune
evasive
compared
to
other
XBB
variants,
consistent
with
antigenic
distances.
Importantly,
distinct
mAb
S309
was
unable
neutralize
BA.2.86,
likely
due
a
D339H
mutation
based
on
modeling.
had
relatively
high
fusogenicity
in
CaLu-3
cells
but
low
fusion
293T-ACE2
some
suggesting
potentially
differences
conformational
stability
Spike.
Overall,
our
study
underscores
importance
surveillance
need
for
updated
COVID-19
vaccines.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 27, 2023
Summary
COVID-19
vaccines
have
recently
been
updated
with
the
spike
protein
of
SARS-CoV-2
XBB.1.5
subvariant
alone,
but
their
immunogenicity
in
humans
has
yet
to
be
fully
evaluated
and
reported,
particularly
against
emergent
viruses
that
are
rapidly
expanding.
We
now
report
administration
an
monovalent
mRNA
vaccine
(XBB.1.5
MV)
uninfected
individuals
boosted
serum
virus-neutralization
antibodies
significantly
not
only
(27.0-fold)
currently
dominant
EG.5.1
(27.6-fold)
also
key
like
HV.1,
HK.3,
JD.1.1,
JN.1
(13.3-to-27.4-fold).
In
previously
infected
by
Omicron
subvariant,
neutralizing
titers
were
highest
levels
(1,504-to-22,978)
all
viral
variants
tested.
While
immunological
imprinting
was
still
evident
vaccines,
it
nearly
as
severe
authorized
bivalent
BA.5
vaccine.
Our
findings
strongly
support
official
recommendation
widely
apply
further
protect
public.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(2), P. 184 - 184
Published: Jan. 25, 2024
Over
the
last
three
years,
pandemic
of
COVID-19
has
had
a
significant
impact
on
people’s
lives
and
global
economy.
The
incessant
emergence
variant
strains
compounded
challenges
associated
with
management
COVID-19.
As
predominant
from
late
2021
to
present,
Omicron
its
sublineages,
through
continuous
evolution,
have
demonstrated
iterative
viral
fitness.
comprehensive
elucidation
biological
implications
that
catalyzed
this
evolution
remains
incomplete.
In
accordance
extant
research
evidence,
we
provide
review
subvariants
Omicron,
delineating
alterations
in
immune
evasion,
cellular
infectivity,
cross-species
transmission
potential.
This
seeks
clarify
underpinnings
biology
within
SARS-CoV-2,
thereby
providing
foundation
for
strategic
considerations
post-pandemic
era
Protein & Cell,
Journal Year:
2024,
Volume and Issue:
15(6), P. 403 - 418
Published: March 4, 2024
Intensive
selection
pressure
constrains
the
evolutionary
trajectory
of
SARS-CoV-2
genomes
and
results
in
various
novel
variants
with
distinct
mutation
profiles.
Point
mutations,
particularly
those
within
receptor
binding
domain
(RBD)
spike
(S)
protein,
lead
to
functional
alteration
both
engagement
monoclonal
antibody
(mAb)
recognition.
Here,
we
review
data
RBD
point
mutations
possessed
by
major
discuss
their
individual
effects
on
ACE2
affinity
immune
evasion.
Many
single
amino
acid
substitutions
epitopes
crucial
for
evasion
capacity
may
conversely
weaken
affinity.
However,
this
weakened
effect
could
be
largely
compensated
specific
epistatic
such
as
N501Y,
thus
maintaining
overall
protein
all
variants.
The
predominant
direction
evolution
lies
neither
promoting
nor
evading
mAb
neutralization
but
a
delicate
balance
between
these
two
dimensions.
Together,
interprets
how
efficiently
resist
meanwhile
is
maintained,
emphasizing
significance
comprehensive
assessment
mutations.